about
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivoOverlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.Furin at the cutting edge: from protein traffic to embryogenesis and diseaseAntibody-dependent enhancement of Ebola virus infectionEbola: a holistic approach is required to achieve effective management and controlExperimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialxMAP Technology: Applications in Detection of PathogensThe multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.Identification of a small-molecule entry inhibitor for filoviruses.Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodiesDetection of cell-cell fusion mediated by Ebola virus glycoproteins.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.Chemical and Structural Aspects of Ebola Virus Entry Inhibitors.The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus.Novel Small Molecule Entry Inhibitors of Ebola Virus.The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent.Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entryHost cell factors in filovirus entry: novel players, new insightsTissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.Filovirus tropism: cellular molecules for viral entry.Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein.
P2860
Q21131393-31FDE31B-6DEF-4AF0-8B9E-FF3EDF3123ADQ24541306-3B22B55F-BE6B-43A5-89C3-2C7D00FEB413Q24670432-5FFF82DF-1BCB-483C-85BC-BCC2B97227E5Q24683154-65537F78-0400-49D6-8186-A158E5DF5FD9Q26823792-BB84A1E1-660D-475B-8799-9236FD14860FQ28551448-92B02919-79EF-4C20-B44C-CCD73D06759CQ29247973-D87EA447-6899-4B0F-8034-7C4376448F30Q30376138-709E353E-7AD4-4B91-B7CA-D991DBB56E21Q33804801-04E86D08-0872-4F0C-B2BA-F19FB820CE95Q34059380-3E7CCB4F-3A6F-46F5-8593-9CB155F3B99EQ34170237-332555BA-9892-4CB6-BCF0-1086BD3CED2CQ34257290-A1E30D7A-349A-496D-B838-64CA78AE1EDBQ34289828-C6EB9B79-16AB-4877-9141-9228C9CFDBABQ34435069-A75E189A-77CD-4B28-977E-40F829AE7BC6Q34463780-58D7ABD6-BBFE-4E61-AEB6-87C850C68336Q34464533-E6F84BCA-841B-4301-9C99-1B19D87FCF86Q35105093-669F11B6-A029-46A0-BC37-EC6C5D66C64EQ35589926-449CFC83-32EA-423A-87BD-5AC9B235B973Q35634367-70556B85-5327-46D2-BEE3-5D982065CC19Q35678240-E646F493-6A19-4FDC-B9F7-BD0C5097DD3FQ35709878-D3E4EC8C-3634-4F02-9DB1-476BE52C75BBQ35930819-E80B85B6-FB81-4C68-99F5-3653279ED23FQ36379337-C4193A58-95D1-4A50-93C9-0A34FEF058AAQ36509382-878A59C0-7A5B-4527-B50F-E2A6AD711B04Q38076136-DB0F17E0-F8F5-4F66-BCCA-778A0785C44DQ38258245-26BBC15D-D359-4023-9E92-0C4C5EFA1C7EQ38913439-3A99F413-7636-4A92-BB73-A8F9D1796B69Q38956790-6B523DFD-D591-48D1-B56B-B3D3EDA38FEFQ40295070-29002858-F8AD-452F-883E-91DE7A0C94F6Q47256875-764F5311-1FC4-4025-A432-6FD83CB08E36
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The pathogenesis of Ebola hemorrhagic fever.
@ast
The pathogenesis of Ebola hemorrhagic fever.
@en
type
label
The pathogenesis of Ebola hemorrhagic fever.
@ast
The pathogenesis of Ebola hemorrhagic fever.
@en
prefLabel
The pathogenesis of Ebola hemorrhagic fever.
@ast
The pathogenesis of Ebola hemorrhagic fever.
@en
P1476
The pathogenesis of Ebola hemorrhagic fever.
@en
P2093
P304
P356
10.1016/S0966-842X(01)02201-6
P577
2001-10-01T00:00:00Z